drugset / Trial / NCT00084253
Study of Boosted Atazanavir (ATV) Versus Non-boosted ATV in Naive Patients
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to find out if 300 mg of ATV plus 100 mg of ritonavir (RTV) works as well as 400 mg of ATV alone as part of a regimen with stavudine XR and lamivudine to slow or stop the progression of HIV infection in patients who have never used anti-HIV drugs.
Timeline
- Start
- 2004-06
- Primary completion
- 2006-08
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Atazanavir | Other / unclassified | 300 mg | Oral |
| Comparator | Atazanavir | Other / unclassified | 400 mg | Oral |
| Comparator | Lamivudine | Other / unclassified | 300 mg | Oral |
| Comparator | Ritonavir | Other / unclassified | 100 mg | Oral |
| Comparator | Stavudine | Other / unclassified | 100 mg | Oral |